HRTX - Heron Therapeutics EPS misses by $0.03 beats on revenue February, 24 2021 08:57 AM Heron Therapeutics Inc. Heron Therapeutics (HRTX): Q4 GAAP EPS of -$0.68 misses by $0.03.Revenue of $20.61M (-41.3% Y/Y) beats by $1.27M.Press Release For further details see: Heron Therapeutics EPS misses by $0.03, beats on revenue